Complications of cardiac catheterization in the current era: A single-center experience

✍ Scribed by Baskaran Chandrasekar; Serge Doucet; Luc Bilodeau; Jacques Crepeau; Pierre deGuise; Jean Gregoire; Richard Gallo; Gilles Cote; Raoul Bonan; Michel Joyal; Gilbert Gosselin; Jean-François Tanguay; Ihor Dyrda; Marc Bois; Andre Pasternac

• Publisher: John Wiley and Sons
• Year: 2001
• Tongue: English
• Weight: 69 KB
• Volume: 52
• Category: Article
• ISSN: 1522-1946
• DOI: 10.1002/ccd.1067

✦ Synopsis

Abstract

Consecutive cardiac catheterization procedures done over a 2‐yr period (April 1996 to March 1998) were prospectively analyzed to determine and characterize procedure‐related complications (in‐hospital and 1‐mo follow‐up), as they occur at present. During the study period, 11,821 procedures (7,953 diagnostic and 3,868 therapeutic) were performed. The majority of procedures (> 60%) were done in high‐risk patients. Stents were implanted in 33% of patients, and adjunctive abciximab was used in 6.6% of therapeutic procedures. The overall complication rate was 8% (3.6% of diagnostic procedures and 15.1% of therapeutic procedures). The procedure‐related mortality rates were 0.2%, 0.1%, and 0.5% for total, diagnostic, and therapeutic procedures, respectively. Cardiac complications were seen in 3.9% (1.5% of diagnostic and 9% of therapeutic procedures). Emergency cardiac surgery was required in 0.05% of the diagnostic procedure group and 0.3% of the therapeutic procedure group (total, 0.1%). Despite marked changes in patient population and practice, the complication rates of cardiac catheterization remain very low. Cathet Cardiovasc Intervent 2001;52:289–295. © 2001 Wiley‐Liss, Inc.